BioRestorative Therapies Changes Accountants
Ticker: BRTX · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1505497
Sentiment: neutral
Topics: auditor-change, administrative
TL;DR
BioRestorative Therapies switched accountants, no drama reported.
AI Summary
BioRestorative Therapies, Inc. announced a change in its certifying accountant on April 16, 2025. The company's previous independent registered public accounting firm was Semple, Benner, Marotta & Co., P.C. The audit committee of the Board of Directors did not inform Semple, Benner, Marotta & Co., P.C. of any disagreements or reportable events.
Why It Matters
A change in auditors can sometimes signal underlying issues with financial reporting or internal controls, though in this case, no disagreements were reported.
Risk Assessment
Risk Level: low — This filing reports a routine administrative change in the company's auditors without any indication of disputes or financial irregularities.
Key Players & Entities
- BioRestorative Therapies, Inc. (company) — Registrant
- Semple, Benner, Marotta & Co., P.C. (company) — Previous certifying accountant
- April 16, 2025 (date) — Date of earliest event reported
FAQ
Who is BioRestorative Therapies, Inc.'s new certifying accountant?
The filing does not disclose the name of the new certifying accountant, only that there has been a change.
When was the change in certifying accountant effective?
The earliest event reported is April 16, 2025, indicating the change occurred on or before this date.
Were there any disagreements with the former accountant, Semple, Benner, Marotta & Co., P.C.?
No, the filing explicitly states that the audit committee did not inform Semple, Benner, Marotta & Co., P.C. of any disagreements or reportable events.
What was the previous accountant's role?
Semple, Benner, Marotta & Co., P.C. was the independent registered public accounting firm for BioRestorative Therapies, Inc.
Does this filing indicate any financial reporting issues?
No, the filing states there were no disagreements or reportable events with the former accountant, suggesting no immediate financial reporting issues are being highlighted by this change.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding BioRestorative Therapies, Inc. (BRTX).